A Randomized Controlled Trial Assessing the Impact of a Repair Balm with Prebiotic and Panthenol on the Tolerability of Topical 5-Fluorouracil Therapy for Actinic Keratoses - Top-Institutions - MDSpire

A Randomized Controlled Trial Assessing the Impact of a Repair Balm with Prebiotic and Panthenol on the Tolerability of Topical 5-Fluorouracil Therapy for Actinic Keratoses

  • By

  • Anne Tseng

  • Regina Yu

  • Susan Brown

  • Nicholas Muller

  • Samuel X. Tan

  • Edwige Roy

  • Suzanne Nguyen

  • Delphine Kerob

  • Kiarash Khosrotehrani

  • April 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Dermatology
    • Oncology
    • Skin Cancer Research

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Dermatology
    • Oncology
    • Cutaneous Oncology

  • #3

    University of Sydney, Melanoma Institute Australia
    University of Sydney, Melanoma Institute Australia

    Sydney, NSW

    Key Differentiators

    • Dermatology
    • Skin Cancer Research
    • Clinical Trials

  • #4

    Dana-Farber/Brigham and Women’s Cancer Center
    Dana-Farber/Brigham and Women’s Cancer Center

    Boston, MA

    Key Differentiators

    • Dermatology
    • Oncology
    • Cutaneous Oncology

Original Source(s)

A Randomized Controlled Trial Assessing the Impact of a Repair Balm with Prebiotic and Panthenol on the Tolerability of Topical 5-Fluorouracil Therapy for Actinic Keratoses

  • by Anne Tseng, Regina Yu, Susan Brown, Nicholas Muller, Samuel X. Tan, Edwige Roy, Suzanne Nguyen, Delphine Kerob, Kiarash Khosrotehrani

  • April 29, 2026

Related Content

Radiotherapy plus immunotherapy with or without chemotherapy improves survival in elderly esophageal squamous cell carcinoma: a real-world comorbidity-stratified study

Correction: Neoadjuvant and/or adjuvant immune checkpoint inhibitors combined with chemotherapy for locally advanced resectable penile squamous cell carcinoma

Skin tumor identification by means of convolutional neural network and improved gray wolf optimizer